Amiloride inhibits anti-Ig induction of proliferation in a human B-lymphoma cell population.
The effects of amiloride on increased 86Rb+ influx, an early event of lymphocyte activation, and on the late event, [3H]thymidine uptake, were compared in anti-Ig-stimulated human B-lymphoma cells in vitro. Both events were inhibited to significant and comparable extents, and the drug effects were apparently not due to unspecific toxicity. This suggests that the increased 86Rb+ influx reflects early changes (e.g. amiloride-sensitive Na+-H+ exchange) which are required for anti-Ig induction of B-lymphocyte proliferation.